AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
NAUT vs NAMSW Fundamental Comparison
| Metric | NAUT | NAMSW |
|---|---|---|
| Revenue | N/A | $22.5M |
| Net Income | $-59.0M | $-203.8M |
| Net Margin | N/A | -905.7% |
| ROE | -37.6% | -29.8% |
| ROA | -30.9% | -26.5% |
| Current Ratio | 13.33x | 7.88x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.47 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAUT vs NAMSW: Frequently Asked Questions
Is NAUT or NAMSW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. NAUT is rated STRONG SELL (88% confidence) while NAMSW is rated STRONG SELL (88% confidence). This is not investment advice.
How does NAUT compare to NAMSW fundamentally?
Nautilus Biotechnology, Inc. has ROE of -37.6% vs NewAmsterdam Pharma Co N.V.'s -29.8%. Net margins are N/A vs -905.7% respectively.
Which stock pays higher dividends, NAUT or NAMSW?
NAUT has a dividend yield of N/A or no dividend while NAMSW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAUT or NAMSW for long term?
For long-term investing, consider that NAUT has STRONG SELL rating with 88% confidence, while NAMSW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAUT vs NAMSW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAUT vs NAMSW, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.